Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shantha was India’s first biotech to develop an indigenously produced recombinant hepatitis B vaccine launched in 1997 at affordable prices. It developed multiple WHO-prequalified pediatric combination vaccines. The company faced challenges after WHO cancelled prequalification of its pentavalent vaccine but survived through support from parent Sanofi. It has expanded into oncology biosimilars and small molecules alongside its strong vaccine portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shantha Biotechnics.